Azilsartan Medoxomil (Edarbi): The Eighth Angiotensin II Receptor Blocker
- PMID: 22346296
- PMCID: PMC3278144
Azilsartan Medoxomil (Edarbi): The Eighth Angiotensin II Receptor Blocker
Figures
References
-
- Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289:2560–2572. - PubMed
-
- Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med. 2010;38:600–609. - PubMed
-
- Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation. 2011;123(8):933–944. - PubMed
-
- Wilmington, Del.: AstraZeneca; Apr, 2011. Atacand (candesartan celexetil), prescribing information.
-
- East Hanover, N.J.: Novartis; Apr, 2011. Diovan (valsartan), prescribing information.
LinkOut - more resources
Full Text Sources